Literature DB >> 7878804

Intraoperative high-dose anti-T-lymphocyte globulin bolus in addition to triple-drug therapy improves kidney graft survival.

J Kaden1, G May, P Müller, J Groth, V Strobelt, E Eger, L Wohlfahrt.   

Abstract

Mesh：

Substances：

Year:  1995        PMID： 7878804

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  3 in total

1.  Efficacy of anti-T-lymphocyte globulin-Fresenius as an induction agent in deceased-donor renal transplantation: A cohort study.

Authors:  Yun-Xia Chai; Jian-Lei Ji; Shu-Juan Li; Yan-Wei Cao; Xiao-Xia Sun; Qing-Hai Wang; Tao Huang; Zhen Dong; Hong-Yang Wang
Journal:  Exp Ther Med       Date:  2020-01-15       Impact factor: 2.447

2.  Long-term evaluation of single bolus high dose ATG induction therapy for prophylaxis of rejection in live donor kidney transplantation.

Authors:  Hussein A Sheashaa; Ahmed F Hamdy; Mohamed A Bakr; Sherif F Abdelbaset; Mohamed A Ghoneim
Journal:  Int Urol Nephrol       Date:  2008       Impact factor: 2.370

3.  Modest dose anti-thymocyte globulin administered intraoperatively is safe and effective in kidney transplantations: a retrospective study.

Authors:  Hui-Ying Liu; Yuan-Tso Cheng; Hao Lun Luo; Chiang-Chi Huang; Chien Hsu Chen; Yuan-Chi Shen; Wen-Chin Lee
Journal:  PeerJ       Date:  2019-08-16       Impact factor: 2.984
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.